Medicine News and Research

RSS

Canary Foundation to implement biosensor technologies for early cancer detection

Canary Foundation has committed to being the first organization to implement the breakthrough in biosensor technologies in its research pipeline. The new technology promises to revolutionize the early detection cancer field.

12 Oct 2009

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

Researchers at Adaptimmune Limited and the University of Pennsylvania School of Medicine, have announced the approval of an Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) and opening for enrolment of the first ever study using patients’ cells carrying an engineered T cell receptor to treat HIV (SL9 HA-GAG-TCR). The trial may have important implications in the development of new treatments for HIV potentially slowing – or even preventing – the onset of AIDS.

11 Oct 2009

Recent releases in Global Health

A Lancet comment examines an Affordable Medicines Facility for malaria (AMFm) program to help countries procure subsidized artemisinin-based combination treatments (ACTs).

9 Oct 2009

Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).

9 Oct 2009

Today's editorials and opinions

After years of struggling with costs that were eating into his bottom line, David White, a small business owner in Maine, recently dropped health insurance for himself and his employees. It was a nerve-wracking decision (Sen. Mary Landrieu, D-La., 10/8).

9 Oct 2009

Riley Hospital for Children commences patient enrollment in clinical trial of cystic fibrosis drug

The Riley Hospital for Children Cystic Fibrosis Center is the first site in the nation to enroll patients ages 6-11 for the first part of a 48-week clinical trial of a promising investigational treatment for cystic fibrosis (CF).

9 Oct 2009

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Health Discovery Corporation, is pleased to announce that it has retained The Dilenschneider Group, headquartered in New York City, to manage the Company’s investor and media relations work. With offices in New York, Washington, DC and Chicago, the Dilenschneider Group provides its clients with some of the finest and most seasoned communications professionals in the world.

9 Oct 2009

Health policy research roundup

Urban Institute: Variation in Insurance Coverage Across Congressional Districts New Estimates from 2008 -- Drawing from data from the American Community Survey, the authors of this brief explore the variation in rates of uninsurance, public and private coverage across congressional districts.

9 Oct 2009

Arizona clinic stops accepting Medicare, some Penn. Medicare Advantage plans cancelled

The Arizona Republic reports: "One of the Mayo Clinic's two family-medicine practices in Arizona soon will stop accepting Medicare, leaving thousands of patients to pay out of pocket for routine doctor's visits or find a new physician." The changes go in effect on Jan. 1 and apply to primary-care services at the Mayo Clinic Family Medicine-Arrowhead.

9 Oct 2009

Learning new tasks causes changes in spontaneous brain activity patterns: Study

Spontaneous brain activity formerly thought to be "white noise" measurably changes after a person learns a new task, researchers at Washington University School of Medicine in St. Louis and the University of Chieti, Italy, have shown.

9 Oct 2009

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

A comprehensive study has revealed, for the first time, the impact of swine flu on the health of the general public in Australia and New Zealand.

9 Oct 2009

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

Solvay Pharmaceuticals, Inc. announced that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release Capsules, the most prescribed pancreatic enzyme replacement therapy (PERT) in the United States, significantly improves a key measure of fat absorption in patients with CF who suffer from exocrine pancreatic insufficiency (EPI).

9 Oct 2009

Calcium to cure cardiovascular problems

Calcium is crucial for heart regeneration by cardiac stem cells following cardiovascular problems say scientists in an article to be published in the journal Circulation Research this 9th of October.

9 Oct 2009

FDA Advisory Committee approves use of Selzentry tablets in combination with HIV therapy

Pfizer Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Antiviral Drugs Advisory Committee voted (10 to 4) to recommend the approval of Selzentry (maraviroc) tablets for use in treatment-naïve adult patients with CCR5-tropic HIV-1 virus as part of combination therapy.

9 Oct 2009

Uvopalatopharyngoplasty surgery is effective for treating sleep apnea disorder

According to research recently published by an Oregon Health & Science University scientist, a form of surgery called uvopalatopharyngoplasty is effective for treating certain patients who suffer from sleep apnea, one of the most common sleep disorders.

9 Oct 2009

Continuing education virtual lecture to help prevent fungal infections in HSCT recipients

Systemic fungal infections are a serious complication of hematopoietic stem cell transplantation (HSCT) and are associated with significant mortality in HSCT recipients. It is critical for healthcare professionals to be aware of the risk factors for fungal infections in HSCT patients and apply optimal strategies for prevention and treatment in this population.

9 Oct 2009

New York Governor participates in roundtable discussion on stem cell research

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

9 Oct 2009

Physician shortage affects older Americans' access to basic care

As members of Congress debate what form a national health care plan should take, older Americans continue to suffer the consequences of a physician shortage that makes accessing basic care a struggle. Barriers to care could be greatly eased, however, by legislation that lifts restrictions preventing physician assistants (PAs) from treating Medicare patients.

9 Oct 2009

NIAID awards $60M for research contracts to discover new adjuvants

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded six new research contracts to discover and characterize novel adjuvants, substances that can be added to vaccines to enhance the protective immune response they induce.

9 Oct 2009

New technique developed to assess individual's risk for type 1 diabetes

A sophisticated computational algorithm, applied to a large set of gene markers, has achieved greater accuracy than conventional methods in assessing individual risk for type 1 diabetes.

9 Oct 2009

Medicine News and Research

Canary Foundation to implement biosensor technologies for early cancer detection

World’s first engineered T cell receptor trial opens with new cellular therapy for HIV

Recent releases in Global Health

Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Today's editorials and opinions

Riley Hospital for Children commences patient enrollment in clinical trial of cystic fibrosis drug

Health Discovery retains Dilenschneider Group to manage its investor and media relations work

Health policy research roundup

Arizona clinic stops accepting Medicare, some Penn. Medicare Advantage plans cancelled

Learning new tasks causes changes in spontaneous brain activity patterns: Study

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

Calcium to cure cardiovascular problems

FDA Advisory Committee approves use of Selzentry tablets in combination with HIV therapy

Uvopalatopharyngoplasty surgery is effective for treating sleep apnea disorder

Continuing education virtual lecture to help prevent fungal infections in HSCT recipients

New York Governor participates in roundtable discussion on stem cell research

Physician shortage affects older Americans' access to basic care

NIAID awards $60M for research contracts to discover new adjuvants

New technique developed to assess individual's risk for type 1 diabetes

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News